OMNICELL,INC. (NASDAQ:OMCL) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition
On July27, 2017, Omnicell,Inc. issued a press release announcing its financial results for the quarter ended June30, 2017. The full text of the press release issued in connection with the announcement is attached as Exhibit99.1 to this Current Report on Form8-K and is incorporated herein by reference.
The information in this Form8-K and the Exhibitattached hereto shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 2.02 Financial Statements and Exhibits
(d)Exhibits
|
Number |
DescriptionofDocument |
|
99.1 |
Press release entitled "Omnicell Achieves Record Revenue in the Second Quarter 2017" dated July 27, 2017 |
OMNICELL, Inc ExhibitEX-99.1 2 exhibit991q217.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Contact: Peter Kuipers Omnicell,…To view the full exhibit click here
About OMNICELL,INC. (NASDAQ:OMCL)
Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.
